INTRODUCTION
Eukaryotic cells continuously produce reactive oxygen species (ROS) from multiple sources, including mitochondrial electrontransport-chain components and a variety of soluble proteins and enzymic systems, such as NADPH oxidase during phagocytosis [1] . Major ROS include superoxide, hydrogen peroxide (H # O # ) and hydroxyl radical, as well as nitric oxide. ROS have been described as essential second messengers in several metabolic pathways and also in the transduction-signal cascade leading to the activation of a number of transcription factors, including the nuclear transcription factor κB (NFκB) and the activator protein-1 (AP-1). Thus, ROS control the inducible expression of a number of genes involved in cell growth and differentiation, inflammation and immune responses and cellular stress [2] [3] [4] [5] [6] . Post-transcriptional regulation is also influenced by ROS. The translation of ferritin-specific mRNA, for example, depends on the redox state of the iron-response element, RNA-binding protein [7] .
However, at high concentrations, ROS are cytotoxic for cells, leading to irreversible damage to DNA, proteins and lipids. Thus, cellular homoeostasis requires the intracellular concentrations and toxic activities of ROS to be finely balanced with the co-ordinated induction of proteins with radical-scavenging properties and protective activities, such as superoxide dismutase, ferritin, haem oxygenase, thioredoxin (TRX) and heat-shock proteins (HSP). The induction of genes coding for these proteins is a crucial step in the cellular response to oxidative stress.
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threitol and the endogenous reductor thioredoxin (TRX), while the effects of iodoacetic acid were irreversible. In addition, TRX also restored the DNA-binding activity of HSF oxidized in i o, while it was found to be itself induced in i o by both HS and H # O # . Thus, H # O # exerts dual effects on the activation and the DNA-binding activity of HSF : on the one hand, H # O # favours the nuclear translocation of HSF, while on the other, it alters HSF-DNA-binding activity, most likely by oxidizing critical cysteine residues within the DNA-binding domain. HSF thus belongs to the group of ROS-modulated transcription factors. We propose that the time required for TRX induction, which may restore the DNA-binding activity of oxidized HSF, provides an explanation for the delay in heat-shock protein synthesis upon exposure of cells to ROS.
proteins containing both constitutively expressed and stressinducible members, usually classified according to their molecular mass, structure, functions and main inducers. In unstressed cells, HSP function as molecular chaperones, contributing to the folding and assembly of nascent polypeptides and to protein transport and degradation, as well as preventing stress-mediated accumulation of misfolded or damaged proteins. Thus, HSP protect cells and tissues under a number of conditions associated with oxidative damage, such as ischaemia-reperfusion [8] or tumour necrosis factor α cytotoxicity [9, 10] .
Transcriptional induction of heat-shock genes requires the activation of the heat-shock factor (HSF), which binds to the consensus heat-shock element (HSE) located in the promoter region of the heat-shock (HS) genes [11] [12] [13] . In unstressed cells, the HSF exists in a non-DNA-binding, cytoplasmic form. Activation of HSF into a DNA-binding form is accompanied by oligomerization and nuclear translocation. To date, two HSF have been identified in mammalian cells, HSF-1 and HSF-2 [14] .
Previous studies have reported that while ROS induce Drosophila and human HSF-DNA-binding activity, HSP were not synthesized, or only weakly so [15, 16] . Based on the observation that the oxidation of conserved redox-reactive cysteines in the DNA-binding domains of mammalian transcriptional regulators, such as NFκB and AP-1, modulates their DNA-binding activity [17] , we hypothesized that alterations in the cellular redox state might also regulate, either positively or negatively, activation and binding of HSF. Indeed, HSF contains three cysteine residues within its DNA-binding domain [18] .
Here we report that H # O # exerted a dual effect in the human premonocytic line U937 : on the one hand, H # O # induced HSF-DNA binding activity in i o, while on the other, H # O # and other oxidants reversibly inhibited HSF-DNA-binding activity, in itro. This activity was recovered, in itro, in the presence of excess thiol. Accordingly, we examined the possibility that the cellular redox-active protein, TRX, is the physiological mechanism responsible for restoring HSF-DNA-binding activity and thus regulating HSF activity during oxidative stress. The NADPHdependent TRX system has been described as a general disulphide reductase with specific functions as a hydrogen donor for ribonucleotide reductase and other substrate-reducing enzymes [19] [20] [21] . TRX contributes to the regulation of enzyme and receptor activity via redox control involving reversible thioldisulphide exchange [20, 22] . We found that TRX, whose expression is increased by both HS and H # O # , also functions as an endogenous regeneration system for HSF during oxidative stress.
EXPERIMENTAL

Materials
[γ-$#P]ATP (5000 Ci\mmol), Hyperfilm and the DNA 5h-endlabelling kit were obtained from Amersham (Buckinghamshire, U.K.). Poly(dI-dC) and deoxyribonuclease-free BSA were obtained from Pharmacia Biotech (Piscataway, NJ, U.S.A.). Diazinedicarboxylic acid bis-(N,N-dimethylamide) (diamine), dithiothreitol (DTT), iodoacetic acid (IAA), N-ethylmaleimide (NEM), 2-mercaptoethanol (2-ME) and protease inhibitors were purchased from Sigma Biochemicals (St. Louis, MO, U.S.A.). A reduced form of recombinant human TRX and goat antibody against human TRX were obtained from IMCO (Stockholm, Sweden). Protein concentrations were determined by the bicinchoninic acid method (Pierce, Rockford, IL, U.S.A.). Polyclonal antibodies against HSF-1 and HSF-2, prepared as described by Sarge et al. [23] , were a gift from Dr. R. Morimoto (Northwestern University, Evanston, IL, U.S.A.).
Cell culture and treatment
The human pre-monocytic cell line U937 was maintained mycoplasma-free in stationary cultures in RPMI 1640 medium (Gibco, Paisley, Scotland, U.K.) supplemented with 10 % (v\v) fetal calf serum (Gibco) and 1 % (v\v) glutamine (Gibco), at 37 mC, in a humidified atmosphere (95 % air\5 % CO # ). For HS, U937 cells were incubated in a water-bath at 44 mC for 20 min and immediately prepared for nuclear extracts. U937 cells were treated for 1 h at 37 mC with concentrations of H # O # ranging from 0.2 to 5 mM. In all other experiments U937 cells were exposed to 2 mM H # O # for 1 h unless otherwise specified.
Preparation of nuclear and cytosolic extracts and gel mobilityshift assays
Preparation of nuclear-protein extracts was adapted from the method described by Dignam et al. [24] . Briefly, cells were collected, kept on ice for 10 min in a hypotonic lysis buffer containing 10 mM Hepes (pH 7.9), 1.5 mM MgCl # , 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF and 1 µg\ml each of antipapain, leupeptin and pepstatin. Nuclear pellets were resuspended in an extraction buffer [10 mM Hepes, pH 7.9\400 mM NaCl\1.5 mM MgCl # \0.1 mM EDTA\0.5 mM DTT\0.2 mM PMSF\5 % (v\v) glycerol] with constant mixing for 30 min at 4 mC. The samples were centrifuged at 65 000 g for 15 min at 4 mC and the supernatant dialysed against a buffer containing 20 mM Hepes (pH 7.9), 75 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF and 20 % (v\v) glycerol. Samples were quickly frozen in liquid nitrogen and stored at k80 mC. Nuclear extracts were then analysed for HSE-binding activity by gel mobility-shift assays. Binding reactions were performed for 30 min at 25 mC by adding 5 µg of nuclear proteins to a mixture containing 10' c.p.m. of [γ$#P]ATP end-labelled, double-stranded HSE oligonucleotide (5hGCCTCGAATGTTCGCGAAGTT3h) in 15 µl of dialysis buffer containing 2 µg of poly(d[I-C]) and 10 µg of BSA. For the competition experiments, either a 100-fold molar excess of nonradioactive HSE or a 100-fold molar excess of the tumourpromoting agent responsive element oligonucleotide (5hCTTGTGAGTCATTCC3h) was used. Samples were electrophoresed on a non-denaturing 4 % polyacrylamide gel, dried and autoradiographed. In experiments aiming to identify which HSF was activated by HS or H # O # , nuclear proteins were pre-incubated for 15 min with a 1 : 50 (v\v) dilution of polyclonal rabbit antibodies against HSF-1 or HSF-2.
Oxidoreductive reactions in vitro
The nuclear extracts of heat-shocked cells, which therefore contain activated HSF, were also treated with either H # O # (1 mM), diamine, IAA or NEM (10 mM each) for 15 min at room temperature. Reduction was obtained by adding for an additional 15 min various reducing reagents such as DTT (10 mM), 2-ME [1 % (v\v)] or TRX (80 µM).
Analysis of TRX expression
U937 cells were incubated for different times with H
# O # (2 mM). Cells were washed and lysed, and aliquots corresponding to equal amounts of proteins (70 µg) were resolved by SDS\PAGE, according to the method of Laemmli [25] , using 15 % polyacrylamide, then transferred to nitrocellulose. Samples were probed with a goat polyclonal antibody against human TRX and bound antibodies were revealed with an anti-(goat IgG-alkaline phosphatase) conjugate (Sigma) in the presence of 5-bromo-4-chloro-3-indolyl phosphate\Nitro Blue Tetrazolium (BCIP\ NBT) as the substrate (Sigma).
Analysis of protein synthesis
In these experiments, RPMI 1640 was replaced by RPMI 1640 without methionine (Gibco). U937 cells were incubated in a water-bath at 44 mC for 20 min, followed by a recovery period of 2.5 h at 37 mC. Labelling was performed with [$&S]methionine (6 µCi\ml) (specific activity 1000 Ci\mmol ; Amersham) for 90 min at 37 mC. U937 cells were incubated with H # O # (2 mM) for 4, 6, 8 and 16 h at 37 mC. [$&S]Methionine was added to the cells for the last 90 min of treatment. Aliquots corresponding to equal cell numbers were resolved by SDS\PAGE (with 10 % polyacrylamide) and revealed by autoradiography. Hsp70 expression was characterized by Western blotting. Proteins were electrophoresed, transferred to nitrocellulose membranes and probed with a mouse monoclonal antibody against the human inducible hsp70 (SPA810, StressGen Biotechnologies, Victoria, Canada). Bound antibodies were revealed with anti-(mouse IgG-peroxidase) conjugate (Sigma) in the presence of H # O # and 4-chloro-1-naphthol (Sigma).
RESULTS
Inducible HSF-1-DNA-binding activity in heat-shocked and H 2 O 2 -treated cells
The activation of HSF and its DNA-binding capacity can be determined by gel mobility-shift assays using the synthetic oligonucleotide containing the consensus HSE-binding site from the human HSP promoter. (A) U937 cells were exposed to HS (lanes 2-4) or to H 2 O 2 (2 mM) for 1 h at 37 mC (lanes 5-7). Nuclear proteins (5 µg) were subjected to gel mobility-shift assay using [ 32 P]HSE. The specificity of HSF-HSE-binding activity was controlled by competition experiments with a 100-fold molar excess of cold HSE (lanes 3 and 6) or tumour promoting agent responsive element (TRE) (lanes 4 and 7). Both HS and H 2 O 2 induced HSF-HSE binding, but less with H 2 O 2 than with HS. (B) Nuclear proteins prepared from cells exposed to HS (lanes 2-4) or to H 2 O 2 (lanes 5-7) were pre-incubated with polyclonal antibodies specific for either HSF-1 (lanes 3 and 7) or HSF-2 (lanes 4 and 6). Both stresses activated HSF-1. 7) , whereas antibodies to HSF-2 had no effect (lanes 4 and 6).
Experiments performed with concentrations of H # O # ranging from 0.2 mM to 5 mM indicated that the H # O # -mediated HSF activation was concentration-dependent, with a threshold at 
Reversible inactivation of HSF-HSE-binding activity by in vitro oxidation of nuclear extracts
As HSF-HSE-binding activity induced by H # O # appeared qualitatively similar to, but quantitatively different from, that induced by HS, we hypothesized that H # O # might, on one hand, favour the activation of HSF, and on the other, prevent its binding to HSE, by oxidatively altering HSF. We thus investigated the influence, on the DNA-binding capacity of HSF, of oxidative and others agents which can modify free sulphydryl groups. Nuclear translocation of HSF was achieved by exposing the cells to HS. The resulting nuclear extracts were treated with alkylating agents, such as IAA or NEM, or oxidizing agents, such as H # O # or diamine. The results are presented in Figure 3 . Both alkylating agents (lanes 3 and 4) and oxidants (lanes 5 and 6) abolished HSF-binding to HSE.
TRX reverses the in vitro and in vivo effects of H 2 O 2
The in itro effects of H # O # described above were completely reversed by further treatment with reducing agents such as 2-ME ( Figure 3, lane 11) and DTT (lane 12), or by the endogenous reducing agent TRX (lane 13). Similar reversibility was observed with diamine (results not shown). In contrast, alkylation of nuclear extracts with IAA was not reversible by DTT or TRX (lanes 8 and 9).
We also tested the effects of TRX and DTT on HSF-HSEbinding induced by H # O # in i o. Nuclear extracts from cells exposed to H # O # were treated with TRX or DTT, as mentioned above. Only TRX, but not DTT, was able to regenerate full HSF-binding activity in nuclear extracts from cells previously 
Figure 4 TRX expression is regulated by HS and H 2 O 2
A Western blot for TRX is shown of U937 cells exposed to HS (4 h recovery) (lane 2) or to H 2 O 2 , for the indicated time periods (lanes 3-7) . Equal amounts of proteins were analysed. In addition to the constitutive expression of TRX in unstressed cells (lane 1), both stresses were able to up-regulate TRX expression.
TRX is induced by HS and by H 2 O 2
Having found that TRX prevented the oxidant-induced inhibition of HSF, we hypothesized that TRX might represent a key factor in HSF regulation during oxidative injury in i o. In order to be an efficient regulator under stressful conditions, a protein should be up-regulated during stress. U937 cells were exposed to HS or to H # O # . Equal amounts of proteins were subjected to Western blot analysis using TRX-specific antibodies (Figure 4 ). Lane 1 shows the constitutive expression of TRX in U937 cells. TRX expression was induced by HS (lane 2) and by H # O # in a time-dependent fashion (lanes 3-7).
Kinetics of H 2 O 2 -mediated HSF-HSE-binding activity and HSP synthesis
According to the kinetics of induction of TRX, we hypothesized that the apparent lack of induction of HSP by oxidants, reported
Figure 5 Kinetics of H 2 O 2 -mediated activation and DNA binding of HSF
U937 cells were exposed to HS (lane 2) or to H 2 O 2 (2 mM) for the indicated time periods (lanes 3-9). Nuclear proteins (5 µg) were subjected to gel mobility-shift assay using [ 32 P]HSE. As expected, immediately after HS, HSF-HSE-binding activity was observed. In contrast, H 2 O 2 -induced HSF-HSE complexes were detected only after 90 min.
by others [15, 16] , as well as by ourselves in U937 cells exposed to H # O # [26] , was in fact only delayed for the duration of time required for TRX induction. U937 cells were thus incubated in the presence of H # O # (2 mM), and after the indicated times, nuclear extracts were prepared and tested for HSF-DNA-binding activity. As shown in Figure 5 , compared with HS, which immediately generated HSE-HSF complexes (lane 2), the effect of H # O # was delayed, the maximal HSF-DNA-binding activity 8 and 2) . We have previously reported that H # O # did not induce HSP synthesis in U937 cells [26] . However, we had only investigated the early time-points after H # O # exposure. Exposure of U937 cells for 20 min at 44 mC, followed by a 4 h recovery period at 37 mC, induced the classical HSP (hsp70, 90 and 110), whereas exposure to H # O # (2 mM) for 4 h did not induce HSP synthesis ( Figures 6A and 6B, compare lanes 2 and 3) . Time-course experiments for protein synthesis indicated that there was indeed no induction of HSP up to 4 h after exposure to H # O # , while the H # O # -mediated induction of HSP synthesis (hsp70 and hsp90) started after 6 h incubation with H # O # (lane 4), reached a peak at 8 h (lane 5) and disappeared after 16 h (lane 6). Hsp70 induction was confirmed by Western-blot analysis with specific monoclonal antibodies against hsp70 ( Figure 6B ).
DISCUSSION
The effects of oxidants on the HS response have been studied by a number of groups, including ours, often with conflicting results, suggesting that there is a multi-step and complex regulation of this response according to the cell type, the particular oxidant used, the subcellular location of its production and the time allowed for recovery from stress [16, 26, 27] . We thus investigated the effect of the membrane-permeant H # O # on HSF activation and binding and on HSP synthesis. Our results indicate a dual regulation of HSF by oxidants. This dual regulation appears to be under the control of TRX, a small ubiquitous protein containing two redox-active cysteine residues in the active site, whose reduced form functions as a hydrogen donor for the reduction of protein disulphides [27] . We first confirmed that H # O # led to HSF activation in human cells, and specifically, to the activation of HSF-1, which is also the type of HSF activated by thermal stress, while HSF-2 regulates the activity of HS genes under non-stressful conditions, such as differentiation and development [28] . The activation of HSF by oxidants is selective for the type of oxidant, H # O # being effective while superoxide is not [29] . The selectivity of oxidants in the activation of transcription factors may be a general phenomenon, since it has also been described for NFκB, which, like HSF, is activated by H # O # but not by superoxide [30] . This is not the only similarity in the regulation of HSF and other transcription factors by the redox state. Indeed, while inducing in i o HSF activation, nuclear translocation and some degree of HSF-DNA binding, H # O # oxidatively modified the resulting activated HSF (aHSF) in itro, which prevented its binding to HSE. We propose that this inhibition of HSF-DNAbinding resulted from oxidation of cysteine residue(s) within the DNA-binding domain of HSF-1. NFκB and AP-1 also harbour conserved cysteines within their DNA-binding sites, which have been proposed as the target for the modulatory effects of oxidants and reducing agents on those transcription factors [31] [32] [33] [34] [35] [36] . The effects of oxidants on the DNA-binding activity of these transcription factors are modulated by intracellular thiols which, in turn, are regulated by glutathione and TRX. Interestingly, these antioxidants exert differential effects on NFκB and on AP-1 [37] [38] [39] [40] .
The involvement of a redox mechanism in the HS signaltransduction pathway has recently been suggested by Huang et al. [41] , who showed that the presence of DTT during stress inhibited the HS response. Thus, in order to test the involvement of sulphydryl groups in HSF-HSE complex formation, we examined the effects, in itro, of a number of redox-and thiolreactive agents on HSF-DNA-binding activity. In particular, we investigated the role of TRX, a molecular chaperone which might catalyse, depending on the redox environment, the isomerization, oxidation or reduction of protein thiols\disulphides [19] . We found that oxidation-mediated inhibition of HSF-DNA-binding was reversed by exogenous reducing agents, such as DTT, 2-ME or TRX, while the alkylation-mediated inhibition was irreversible, suggesting that one or more reduced cysteine residue(s) within the DNA-binding domain of HSF are critical for binding. Interestingly, not all HSF contain cysteine residues within their DNA-binding region : for example, human HSF-2 or yeast HSF do not [42, 43] . The selective activation of one or the other HSF might thus depend upon the molecular structure of HSF : human HSF-1 is regulated by redox modifications while HSF-2, in which cysteines are replaced by threonine or tyrosine residues, would be regulated by phosphorylation. The precise involvement of cysteine residues in HSF-HSE-binding activity should be confirmed by site-directed mutagenesis of these residues.
TRX is involved in the regeneration of cellular proteins inactivated by oxidative stress in i o [44] . Accordingly, reduced human recombinant TRX prevented the inhibition of HSF-HSE-binding induced by oxidation in i o, which was not the case for DTT. It is known that TRX, as a protein disulphide reductase, reacts about 10& times faster than DTT [45] . However TRX is itself an enzyme which is also regulated by oxidoreduction of SH groups [45] , and in the absence of other reductants, TRX may be inactivated by SH-group oxidation. While, in i o, TRX is maintained in its reduced form by TRX reductase and NADPH [46] , in our experiments, the amount of DTT contained in the commercial incubation mixture was probably enough to keep TRX reduced.
Both DTT and TRX prevented the H # O # -induced DNAbinding activity of HSF when added before H # O # (results not shown), suggesting that these reductants scavenge H # O # . It has been proposed that TRX not only functions in i o as a proton donor for numerous proteins, but also scavenges ROS (in particular H # O # and hydroxyl radicals) and reactivates denatured proteins that contain mispaired disulphide bonds [47] . However, while the re-folding activity of TRX has been clearly demonstrated [48] , this is not the case for its scanvenging activity. TRX may regulate the scavenging activity of other antioxidants by facilating proton transfer [49] , or exert a direct effect as a freeradical quencher [47, 50, 51] .
However, TRX expression was increased during HS and oxidative stress. The inducible expression of TRX in human cells by both HS and oxidative stress leads us to suggest that TRX might be a new member of the stress-protein families. Interestingly, the recently published sequence of the promoter region of human TRX reveals the presence of many regulatory elements compatible with HSF-responsive elements [52] . We propose that the time required for TRX induction provides an explanation for the lack of HSP synthesis upon exposure of cells to ROS, despite the activation of HSF, as reported in a number of studies [15, 16] . Indeed, the time-dependent induction of TRX by H # O # correlated well with the increase in HSF-DNA-binding activity observed after 120 min of exposure of cells to H # O # . Previous studies were usually limited to 4 h of recovery after stress, a period which in U937 cells, for example, was insufficient to allow the H # O # -mediated induction of HSP synthesis. Figure 7 schematically summarizes the data presented here and their interpretation. HSF is maintained inactivated in i o in the cytoplasm by association with a chaperone, which might be hsp70 (inactivated HSF, iHSF) [53, 54] . Upon exposure to oxidative stress, hsp70 dissociates from HSF favouring its trimerization and nuclear translocation (aHSF). However, cysteine residue(s) in the DNA-binding domain of HSF may also be a substrate for ROS leading to oxidation of HSF (aHSF-oxi), which is unable to bind HSE. Early after oxidative stress, only a small amount of aHSF is functional, while TRX is being induced (' early antioxidants ', aiming at radical scavenging by direct interaction with ROS or regulation of other antioxidants and protection of HSF and other transcription factors). After a prolonged recovery time, up-regulation of TRX catalyses the transformation of aHSF-oxi into the reduced form (aHSF-red), which efficiently interacts with HSE. Then, transcriptional activitation of HS genes occurs until sufficient amounts of HSP are synthesized (' late protection-repair ', i.e., proteins involved in overall protein repair, such as HSP).
In conclusion, the HS response, which depends on the optimal transcriptional activity of HSF, appears to be finely tuned by a balance between oxidants and antioxidants. This equilibrium depends on the type of stress, its consequences for the cellular redox state and the time allowed for recovery. HSF belongs to the ROS-modulated transcription factors and is regulated at two distinct levels : induction\activation and DNA binding. In addition to phosphorylation, which is essential for the transcriptional activity of some HSFs [55] , redox modifications represent another efficient mechanism for controlling the HS response.
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